ArticleKidney medicine2026
Seronegative Cryoglobulinemic Glomerulonephritis Coexisting With Primary Sjögren Syndrome and HBV Infection: A Diagnostic and Therapeutic Challenge.
Article in Kidney medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cryoglobulinemic glomerulonephritis (CryoGN) is most often caused by mixed cryoglobulinemia, encompassing both type II and type III forms. CryoGN is commonly associated with hepatitis C virus infection or primary Sjögren syndrome (pSS). We report a rare case of serum-negative CryoGN that was associated with concomitant pSS and hepatitis B virus (HBV) infection. Kidney biopsy pathology revealed necrotizing and acute exudative proliferative glomerulonephritis with crescents, necrotizing arteritis, interstitial lymphohistiocytic inflammatory infiltrates, and organized deposits with characteristic features of cryoglobulin based on electron microscopy. The patient was first treated with entecavir for HBV suppression, followed by pulse steroids and rituximab, resulting in resolution of kidney dysfunction and proteinuria. This case underscores the importance of kidney biopsy in diagnosing CryoGN in the absence of serum positivity within the appropriate clinical context. It also highlights the role of combination therapy in targeting multiple pathogenic pathways that drive chronic immune stimulation and/or lymphoproliferation. The coexistence of pSS and HBV can trigger CryoGN. A multidisciplinary and individualized therapeutic approach (antiviral and immunosuppressive) can lead to an excellent renal response.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.